Physician profile
Deven Kulkarni
NPI 1306474606
$2,199.69
in general payments reported to CMS, 2019-2025
3 companies · $2,200 in 2025
The $2,200 reported for 2025 was more than what 91% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,473 · Food and Beverage: $583 · Consulting Fee: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,472.75 |
| Food and Beverage | $582.82 |
| Consulting Fee | $144.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $1,966.25 | 2025 | |
| Bard Peripheral Vascular, INC. | $188.36 | 2025 | Encor Enspire |
| Merit Medical Systems INC | $45.08 | 2025 | Savi Scout |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deven Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.